July 9, 2019
A molecular process involved in the action of anti-leukemia drugs has been discovered at Université de Montréal’s Institute for Research in Immunology and Cancer (IRIC). While calling into question a central tenet of oncology, this discovery, published in the journal Cancer Cell, also holds promise for the development of effective treatments in the […]